We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
AUM
$5.02B
AUM Growth
+$1.17B
Cap. Flow
+$816M
Cap. Flow %
16.26%
Top 10 Hldgs %
31.54%
Holding
2,471
New
743
Increased
409
Reduced
522
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 10.76%
2 Financials 10.52%
3 Healthcare 8.02%
4 Industrials 7.74%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWE
2351
DELISTED
World Wrestling Entertainment
WWE
-24,735
Closed -$1.07M
FOCS
2352
DELISTED
Focus Financial Partners Inc. Class A
FOCS
-8,560
Closed -$283K
IDEX
2353
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-748
Closed -$188K
MTEM
2354
DELISTED
Molecular Templates, Inc.
MTEM
-1,506
Closed -$311K
MLVF
2355
DELISTED
Malvern Bancorp, Inc.
MLVF
-12,682
Closed -$161K
GLOP
2356
DELISTED
GASLOG PARTNERS LP
GLOP
-99,499
Closed -$408K
ROCC
2357
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
-28,534
Closed -$272K
RUTH
2358
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-96,417
Closed -$787K
ACOR
2359
DELISTED
Acorda Therapeutics
ACOR
-128
Closed -$11K
JNCE
2360
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-13,738
Closed -$95K
BSMX
2361
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-12,100
Closed -$44K
PRVB
2362
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-40,608
Closed -$573K
CSII
2363
DELISTED
Cardiovascular Systems, Inc.
CSII
-18,824
Closed -$594K
SJR
2364
DELISTED
Shaw Communications Inc.
SJR
-13,970
Closed -$229K
FSTX
2365
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-3,988
Closed -$23K
ONEM
2366
DELISTED
1Life Healthcare
ONEM
-69,526
Closed -$2.52M
LHCG
2367
DELISTED
LHC Group LLC
LHCG
-1,747
Closed -$305K
AVYA
2368
PUT
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-20,000
Closed -$247K
VIVO
2369
DELISTED
Meridian Bioscience Inc
VIVO
-50,071
Closed -$1.17M
BNFT
2370
DELISTED
Benefitfocus, Inc.
BNFT
-111,754
Closed -$1.2M
BIOR
2371
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-64
Closed -$143K
ABMD
2372
DELISTED
Abiomed Inc
ABMD
-12,835
Closed -$3.1M
AERI
2373
DELISTED
Aerie Pharmaceuticals
AERI
-27,013
Closed -$399K
TWTR
2374
DELISTED
Twitter, Inc.
TWTR
-28,753
Closed -$857K
CCXI
2375
DELISTED
ChemoCentryx, Inc.
CCXI
-40,031
Closed -$2.3M

Similar funds

ExodusPoint Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, ExodusPoint Capital Management held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ExodusPoint Capital Management deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.

  • ExodusPoint Capital Management's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
  • ExodusPoint Capital Management added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
  • ExodusPoint Capital Management's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
  • ExodusPoint Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
  • ExodusPoint Capital Management's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
  • ExodusPoint Capital Management opened 743 new positions and closed 789 in Q3 2020.
  • ExodusPoint Capital Management's portfolio value rose 30% quarter-over-quarter to $5.02B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.